Succinic semialdehyde dehydrogenase deficiency

MONDO:0010083

Succinic semialdehyde dehydrogenase (SSADH) deficiency is a rare neurometabolic disorder of gamma-aminobutyric acid (GABA) metabolism with a nonspecific clinical presentation (ranging from mild to severe) with the most frequent symptoms being cognitive impairment with prominent deficit in expressive language, hypotonia, ataxia, epilepsy, and behavioral dysregulation.

Also known as: 4-hydroxybutyric aciduria, SSADH deficiency, gamma-hydroxybutyric aciduria, succinic semialdehyde dehydrogenase deficiency, GABA metabolic defect, SSADHD, Ssadh deficiency, gamma-hydroxybutyricaciduria

25 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by